On 13. Nov. 2025, ICCC reported earnings of -0.02 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 5.51 million, compared to an expected --, with a --% difference. The market reacted with a -10.74% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
What were Immucell Corp's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Immucell Corp reported EPS of -$0.02, missing estimates by --, and revenue of $5.51M, -- -- expectations.
How did the market react to Immucell Corp's Q3 2025 earnings?
The stock price moved down -10.74%, changed from $6.05 before the earnings release to $5.40 the day after.
When is Immucell Corp expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for Immucell Corp's next earnings report?
Based on --
analysts, Immucell Corp is expected to report EPS of -- and revenue of -- for Q4 2025.